The FDA has recently implemented new restrictions concerning COVID-19 vaccine approvals, particularly narrowing eligibility for those under 65. While older Americans will continue to have full access, younger adults and children face limited eligibility. The new guidelines come as COVID-19 cases rise, raising public health concerns and prompting questions about vaccine availability and costs. Health leaders across the U.S. are clarifying these changes as confusion persists. The updated vaccines from Pfizer and Moderna have received restricted approvals, further complicating matters for individuals seeking to get vaccinated this fall.